DarioHealth Q4 EPS $(0.51) Beats $(0.65) Estimate, Sales $6.80M Beat $6.29M Estimate

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.65) by 21.54 percent. This is a 53.21 percent increase over losses of $(1.09) per share from the

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.65) by 21.54 percent. This is a 53.21 percent increase over losses of $(1.09) per share from the same period last year. The company reported quarterly sales of $6.80 million which beat the analyst consensus estimate of $6.29 million by 8.11 percent. This is a 12.77 percent increase over sales of $6.03 million the same period last year.

Total
0
Shares
Related Posts
Read More

Traders More Optimistic Ahead Of Key Consumer Price Index

The CNN Money Fear and Greed index showed an improvement in investor sentiment, after US stocks recorded gains at the start of the week. US inflation data is scheduled for release today, with analysts expecting annual inflation level to ease further during August. Investors also assessed news of Ukraine making some progress against its war with Russia.

AAPL